Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fanconi anemia complementation group A”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00896740
What this trial is testing

Gene Function in Bone Marrow Cells From Patients With Fanconi Anemia and From Healthy Participants

Who this might be right for
Fanconi Anemia
OHSU Knight Cancer Institute 90
Early research (Phase 1)UnknownNCT00006127
What this trial is testing

Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia

Who this might be right for
Fanconi's Anemia
Dana-Farber Cancer Institute 21
Testing effectiveness (Phase 2)Study completedNCT00677079
What this trial is testing

Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Primary Peritoneal CancerAdvanced Epithelial Ovarian Cancer
Sanofi 12
Large-scale testing (Phase 3)Study completedNCT00001806
What this trial is testing

Methods in Education for Breast Cancer Genetics

Who this might be right for
Breast CancerOvarian Cancer
National Cancer Institute (NCI) 170
Not applicableStudy completedNCT02503436
What this trial is testing

C-PATROL - Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer Population

Who this might be right for
Ovarian Cancer, Hereditary Ovarian Cancer Syndrome
AstraZeneca 276
Testing effectiveness (Phase 2)Study completedNCT00494442
What this trial is testing

Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer

Who this might be right for
Ovarian Neoplasm
AstraZeneca 58
Testing effectiveness (Phase 2)Study completedNCT00000603
What this trial is testing

Cord Blood Stem Cell Transplantation Study (COBLT)

Who this might be right for
Anemia, AplasticFanconi AnemiaHematologic Diseases+5 more
National Heart, Lung, and Blood Institute (NHLBI)
Early research (Phase 1)Ended earlyNCT01331018
What this trial is testing

Gene Therapy for Fanconi Anemia

Who this might be right for
Fanconi Anemia
Fred Hutchinson Cancer Center 3
Not applicableUnknownNCT02959398
What this trial is testing

Evaluation of Tomosynthesis for Characterization and the Management of Breast Lesions

Who this might be right for
Breast NeoplasmsTomosynthesisBRCA1 Protein+1 more
Assistance Publique - Hôpitaux de Paris 2,000
Testing effectiveness (Phase 2)Study completedNCT01071239
What this trial is testing

Hematopoietic Stem Cell Transplant for Fanconi Anemia

Who this might be right for
Fanconi Anemia
Medical College of Wisconsin 1
Early research (Phase 1)Study completedNCT01917708
What this trial is testing

Bone Marrow Transplant With Abatacept for Non-Malignant Diseases

Who this might be right for
Hurler SyndromeFanconi AnemiaGlanzmann Thrombasthenia+12 more
Emory University 10
Not applicableLooking for participantsNCT05973656
What this trial is testing

Role of Acetaldehyde in the Development of Oral Cancer

Who this might be right for
Alcohol-Related CarcinomaFanconi AnemiaOral Cavity Carcinoma
Masonic Cancer Center, University of Minnesota 170
Testing effectiveness (Phase 2)WithdrawnNCT06392841
What this trial is testing

Niraparib, Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alterations

Who this might be right for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Deleterious HRR Gene MutationBRCA1 Gene Mutation+7 more
Qian Qin
Testing effectiveness (Phase 2)Looking for participantsNCT06648096
What this trial is testing

Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Fanconi AnemiaHead and Neck Squamous Cell Carcinoma
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 25
Testing effectiveness (Phase 2)Study completedNCT06045052
What this trial is testing

Eltrombopag for Treatment of Fanconi Anemia

Who this might be right for
Fanconi Anemia
Julian Sevilla 8
Testing effectiveness (Phase 2)Study completedNCT00258427
What this trial is testing

Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia

Who this might be right for
Fanconi Anemia
Masonic Cancer Center, University of Minnesota 14
Testing effectiveness (Phase 2)Study completedNCT03377556
What this trial is testing

Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer

Who this might be right for
ATM Gene MutationATR Gene MutationBARD1 Gene Mutation+18 more
SWOG Cancer Research Network 51
Testing effectiveness (Phase 2)Ended earlyNCT00590460
What this trial is testing

Antibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Fanconi Anemia

Who this might be right for
Fanconi AnemiaSevere Aplastic Anemia
Baylor College of Medicine 5
Testing effectiveness (Phase 2)Study completedNCT02797964
What this trial is testing

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Who this might be right for
Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
Sierra Oncology LLC - a GSK company 107
Testing effectiveness (Phase 2)Study completedNCT03157804
What this trial is testing

Lentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype A

Who this might be right for
Fanconi Anemia
Hospital Infantil Universitario Niño Jesús, Madrid, Spain 9
Next Page